Clinical Trials Directory

Trials / Completed

CompletedNCT04531241

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.

Conditions

Interventions

TypeNameDescription
DEVICEACUVUE® OASYS 1-DAYsenofilcon A contact lenses made with a novel manufacturing technology
DEVICEACUVUE® OASYS 1-DAYsenofilcon A contact lenses made with the current manufacturing technology

Timeline

Start date
2020-08-05
Primary completion
2020-09-25
Completion
2020-09-25
First posted
2020-08-28
Last updated
2021-12-14
Results posted
2021-12-14

Locations

7 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04531241. Inclusion in this directory is not an endorsement.